Atıf İçin Kopyala
FİDAN S., ÇAPKIN E., Arica D., DURAK S., Okatan I. E.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.24, sa.2, ss.254-259, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
24
Sayı:
2
-
Basım Tarihi:
2021
-
Doi Numarası:
10.1111/1756-185x.14034
-
Dergi Adı:
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.254-259
-
Anahtar Kelimeler:
antirheumatic therapy, anti‐, tumor necrosis factor therapy, hepatitis B, hepatitis B virus reactivation, hepatitis B virus screening, VIRUS HBV REACTIVATION, OCCULT CARRIERS, PREVENTION, GUIDELINES, SAFETY
-
Karadeniz Teknik Üniversitesi Adresli:
Evet
Özet
Objective The purpose of this study was to determine hepatitis B virus (HBV) screening rates in patients receiving anti-tumor necrosis factor (TNF)-alpha therapy and the frequency of HBV reactivation in patients with resolved hepatitis B virus infection (hepatitis B surface antigen [HBsAg] negative, hepatitis B core antibody [Anti-HBc] positive).